Exosomes derived from epstein-barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells

Journal of Virology

Volumn 87, Issue 18, 2013, Pages 10334-10347

  Nanbo, Asuka ^a   Kawanishi, Eri ^a   Yoshida, Ryuji ^a   Yoshiyama, Hironori ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; DYNAMIN; INTERCELLULAR ADHESION MOLECULE 1;

ARTICLE; B LYMPHOCYTE; CAVEOLA; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOCYTOSIS; EPITHELIUM CELL; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; EXOSOME; GENE IDENTIFICATION; HUMAN; HUMAN CELL; INTERNALIZATION; LATENT PERIOD; LMP1 GENE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; UPREGULATION; VIRUS GENE; VIRUS LATENCY;

B-LYMPHOCYTES; CAVEOLAE; CELL LINE; ENDOCYTOSIS; EPITHELIAL CELLS; EXOSOMES; HERPESVIRUS 4, HUMAN; HUMANS;

EID: 84883301160     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01310-13     Document Type: Article

References (79)

1. Kieff E, Rickinson AB. 2001. Epstein-Barr virus and its replication, p 2511-2573. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Keryer-Bibens C, Pioche-Durieu C, Villemant C, Souquere S, Nishi N, Hirashima M, Middeldorp J, Busson P. 2006. Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9. BMC Cancer 6:283. doi:10.1186/1471-2407-6-283.
3. Meckes DG, Jr, Shair KH, Marquitz AR, Kung CP, Edwards RH, Raab-Traub N. 2010. Human tumor virus utilizes exosomes for intercellular communication. Proc. Natl. Acad. Sci. U. S. A. 107:20370-20375.
4. Middeldorp JM, Pegtel DM. 2008. Multiple roles of LMP1 in Epstein-Barr virus induced immune escape. Semin. Cancer Biol. 18:388-396.
5. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hopmans ES, Lindenberg JL, de Gruijl TD, Wurdinger T, Middeldorp JM. 2010. Functional delivery of viral miRNAs via exosomes. Proc. Natl. Acad. Sci. U. S. A. 107:6328-6333.
6. Pegtel DM, van de Garde MD, Middeldorp JM. 2011. Viral miRNAs exploiting the endosomal-exosomal pathway for intercellular cross-talk and immune evasion. Biochim. Biophys. Acta 1809:715-721.
7. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, Geuze HJ. 1996. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183:1161-1172.
8. Vallhov H, Gutzeit C, Johansson SM, Nagy N, Paul M, Li Q, Friend S, George TC, Klein E, Scheynius A, Gabrielsson S. 2011. Exosomes containing glycoprotein 350 released by EBV-transformed B cells selectively target B cells through CD21 and block EBV infection in vitro. J. Immunol. 186:73-82.
9. Verweij FJ, van Eijndhoven MA, Hopmans ES, Vendrig T, Wurdinger T, Cahir-McFarland E, Kieff E, Geerts D, van der Kant R, Neefjes J, Middeldorp JM, Pegtel DM. 2011. LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-kappaB activation. EMBO J. 30:2115-2129.
10. Sokolova V, Ludwig AK, Hornung S, Rotan O, Horn PA, Epple M, Giebel B. 2011. Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf. B 87:146-150.
11. Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. 1987. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J. Biol. Chem. 262: 9412-9420.
12. Wollert T, Hurley JH. 2010. Molecular mechanism of multivesicular body biogenesis by ESCRT complexes. Nature 464:864-869.
13. Raposo G, Stoorvogel W. 2013. Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 200:373-383.
14. Taverna S, Flugy A, Saieva L, Kohn EC, Santoro A, Meraviglia S, De Leo G, Alessandro R. 2012. Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis. Int. J. Cancer 130:2033-2043.
15. Flanagan J, Middeldorp J, Sculley T. 2003. Localization of the Epstein-Barr virus protein LMP 1 to exosomes. J. Gen. Virol. 84:1871-1879.
16. Gregory CD, Rowe M, Rickinson AB. 1990. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. J. Gen. Virol. 71(Part 7):1481-1495.
17. - RNA supports Burkitt's lymphoma growth through interleukin-10 induction. EMBO J. 19:6742-6750.
18. von Knebel Doeberitz M, Bornkamm GW, zur Hausen H. 1983. Establishment of spontaneously outgrowing lymphoblastoid cell lines with Cyclosporin A. Med. Microbiol. Immunol. 172:87-99.
19. Iwakiri D, Sheen TS, Chen JY, Huang DP, Takada K. 2005. Epstein-Barr virus-encoded small RNA induces insulin-like growth factor 1 and supports growth of nasopharyngeal carcinoma-derived cell lines. Oncogene 24:1767-1773.
20. Seto E, Ooka T, Middeldorp J, Takada K. 2008. Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity. Cancer Res. 68:1030-1036.
21. Seto E, Yang L, Middeldorp J, Sheen TS, Chen JY, Fukayama M, Eizuru Y, Ooka T, Takada K. 2005. Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression. J. Med. Virol. 76:82-88.
22. Sizhong Z, Xiukung G, Yi Z. 1983. Cytogenetic studies on an epithelial cell line derived from poorly differentiated nasopharyngeal carcinoma. Int. J. Cancer 31:587-590.
23. Zhang S, Wu Y, Zeng Y, Zech L, Klein G. 1982. Cytogenetic studies on an epithelioid cell line derived from nasopharyngeal carcinoma. Hereditas 97:23-28.
24. Yao KT, Zhang HY, Zhu HC, Wang FX, Li GY, Wen DS, Li YP, Tsai CH, Glaser R. 1990. Establishment and characterization of two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus and derived from nasopharyngeal carcinomas. Int. J. Cancer 45:83-89.
25. Akiyama S, Amo H, Watanabe T, Matsuyama M, Sakamoto J, Imaizumi M, Ichihashi H, Kondo T, Takagi H. 1988. Characteristics of three human gastric cancer cell lines, NU-GC-2, NU-GC-3 and NU-GC-4. Jpn. J. Surg. 18:438-446.
26. Iwakiri D, Eizuru Y, Tokunaga M, Takada K. 2003. Autocrine growth of Epstein-Barr virus-positive gastric carcinoma cells mediated by an Epstein-Barr virus-encoded small RNA. Cancer Res. 63:7062-7067.
27. Kennedy G, Sugden B. 2003. EBNA-1, a bifunctional transcriptional activator. Mol. Cell. Biol. 23:6901-6908.
28. Yoshiyama H, Imai S, Shimizu N, Takada K. 1997. Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. J. Virol. 71:5688-5691.
29. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP. 1973. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 51: 1417-1423.
30. Eldh M, Lotvall J, Malmhall C, Ekstrom K. 2012. Importance of RNA isolation methods for analysis of exosomal RNA: evaluation of different methods. Mol. Immunol. 50:278-286.
31. Kawamoto T, Ohga N, Akiyama K, Hirata N, Kitahara S, Maishi N, Osawa T, Yamamoto K, Kondoh M, Shindoh M, Hida Y, Hida K. 2012. Tumor-derived microvesicles induce proangiogenic phenotype in endothelial cells via endocytosis. PLoS One 7:e34045. doi:10.1371/journal.pone .0034045.
32. Nanbo A, Imai M, Watanabe S, Noda T, Takahashi K, Neumann G, Halfmann P, Kawaoka Y. 2010. Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog. 6:e1001121. doi:10.1371/journal.ppat.1001121.
33. Moskowitz HS, Yokoyama CT, Ryan TA. 2005. Highly cooperative control of endocytosis by clathrin. Mol. Biol. Cell 16:1769-1776.
34. Manninen A, Verkade P, Le Lay S, Torkko J, Kasper M, Fullekrug J, Simons K. 2005. Caveolin-1 is not essential for biosynthetic apical membrane transport. Mol. Cell. Biol. 25:10087-10096.
35. Kerr MC, Lindsay MR, Luetterforst R, Hamilton N, Simpson F, Parton RG, Gleeson PA, Teasdale RD. 2006. Visualisation of macropinosome maturation by the recruitment of sorting nexins. J. Cell Sci. 119:3967-3980.
36. Mei YP, Zhu XF, Zhou JM, Huang H, Deng R, Zeng YX. 2006. siRNA targeting LMP1-induced apoptosis in EBV-positive lymphoma cells is associated with inhibition of telomerase activity and expression. Cancer Lett. 232:189-198.
37. Escola JM, Kleijmeer MJ, Stoorvogel W, Griffith JM, Yoshie O, Geuze HJ. 1998. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J. Biol. Chem. 273:20121-20127.
38. Orth JD, Krueger EW, Cao H, McNiven MA. 2002. The large GTPase dynamin regulates actin comet formation and movement in living cells. Proc. Natl. Acad. Sci. U. S. A. 99:167-172.
39. Newton AJ, Kirchhausen T, Murthy VN. 2006. Inhibition of dynamin completely blocks compensatory synaptic vesicle endocytosis. Proc. Natl. Acad. Sci. U. S. A. 103:17955-17960.
40. Koivusalo M, Welch C, Hayashi H, Scott CC, Kim M, Alexander T, Touret N, Hahn KM, Grinstein S. 2010. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J. Cell Biol. 188:547-563.
41. Engel S, Heger T, Mancini R, Herzog F, Kartenbeck J, Hayer A, Helenius A. 2011. Role of endosomes in simian virus 40 entry and infection. J. Virol. 85:4198-4211.
42. Chavrier P, Parton RG, Hauri HP, Simons K, Zerial M. 1990. Localization of low molecular weight GTP binding proteins to exocytic and endocytic compartments. Cell 62:317-329.
43. Rybin V, Ullrich O, Rubino M, Alexandrov K, Simon I, Seabra MC, Goody R, Zerial M. 1996. GTPase activity of Rab5 acts as a timer for endocytic membrane fusion. Nature 383:266-269.
44. Ceccarelli S, Visco V, Raffa S, Wakisaka N, Pagano JS, Torrisi MR. 2007. Epstein-Barr virus latent membrane protein 1 promotes concentration in multivesicular bodies of fibroblast growth factor 2 and its release through exosomes. Int. J. Cancer 121:1494-1506.
45. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Brugger B, Simons M. 2008. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319:1244-1247.
46. Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E. 1990. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J. Virol. 64:2309-2318.
47. Morelli AE, Larregina AT, Shufesky WJ, Sullivan ML, Stolz DB, Papworth GD, Zahorchak AF, Logar AJ, Wang Z, Watkins SC, Falo LD, Jr, Thomson AW. 2004. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood 104:3257-3266.
48. Tian T, Wang Y, Wang H, Zhu Z, Xiao Z. 2010. Visualizing of the cellular uptake and intracellular trafficking of exosomes by live-cell microscopy. J. Cell. Biochem. 111:488-496.
49. Tian T, Zhu YL, Hu FH, Wang YY, Huang NP, Xiao ZD. 2012. Dynamics of exosome internalization and trafficking. J. Cell. Physiol. [Epub ahead of print.] doi:10.1002/jcp.24304.
50. Feng D, Zhao WL, Ye YY, Bai XC, Liu RQ, Chang LF, Zhou Q, Sui SF. 2010. Cellular internalization of exosomes occurs through phagocytosis. Traffic 11:675-687.
51. Taraboletti G, D'Ascenzo S, Giusti I, Marchetti D, Borsotti P, Millimaggi D, Giavazzi R, Pavan A, Dolo V. 2006. Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH. Neoplasia 8:96-103.
52. Parolini I, Federici C, Raggi C, Lugini L, Palleschi S, De Milito A, Coscia C, Iessi E, Logozzi M, Molinari A, Colone M, Tatti M, Sargiacomo M, Fais S. 2009. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J. Biol. Chem. 284:34211-34222.
53. Koumangoye RB, Sakwe AM, Goodwin JS, Patel T, Ochieng J. 2011. Detachment of breast tumor cells induces rapid secretion of exosomes which subsequently mediate cellular adhesion and spreading. PLoS One 6:e24234. doi:10.1371/journal.pone.0024234.
54. Nazarenko I, Rana S, Baumann A, McAlear J, Hellwig A, Trendelenburg M, Lochnit G, Preissner KT, Zoller M. 2010. Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res. 70:1668-1678.
55. Nolte-'t Hoen EN, Buschow SI, Anderton SM, Stoorvogel W, Wauben MH. 2009. Activated T cells recruit exosomes secreted by dendritic cells via LFA-1. Blood 113:1977-1981.
56. Rana S, Yue S, Stadel D, Zoller M. 2012. Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection. Int. J. Biochem. Cell Biol. 44:1574-1584.
57. Théry C, Boussac M, Veron P, Ricciardi-Castagnoli P, Raposo G, Garin J, Amigorena S. 2001. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 166:7309-7318.
58. Wubbolts R, Leckie RS, Veenhuizen PT, Schwarzmann G, Mobius W, Hoernschemeyer J, Slot JW, Geuze HJ, Stoorvogel W. 2003. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J. Biol. Chem. 278:10963-10972.
59. Wang D, Liebowitz D, Kieff E. 1985. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840.
60. Sugden B. 1989. An intricate route to immortality. Cell 57:5-7.
61. Kaye KM, Izumi KM, Kieff E. 1993. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. U. S. A. 90:9150-9154.
62. Mainou BA, Everly DN, Jr, Raab-Traub N. 2005. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. Oncogene 24:6917-6924.
63. Dukers DF, Meij P, Vervoort MB, Vos W, Scheper RJ, Meijer CJ, Bloemena E, Middeldorp JM. 2000. Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. J. Immunol. 165:663-670.
64. Mehl AM, Floettmann JE, Jones M, Brennan P, Rowe M. 2001. Characterization of intercellular adhesion molecule-1 regulation by Epstein-Barr virus-encoded latent membrane protein-1 identifies pathways that cooperate with nuclear factor kappa B to activate transcription. J. Biol. Chem. 276:984-992.
65. Peng M, Lundgren E. 1993. Transient expression of the Epstein-Barr virus LMP1 gene in B-cell chronic lymphocytic leukemia cells, T cells, and hematopoietic cell lines: cell-type-independent-induction of CD23, CD21, and ICAM-1. Leukemia 7:104-112.
66. Lam N, Sugden B. 2003. LMP1, a viral relative of the TNF receptor family, signals principally from intracellular compartments. EMBO J. 22:3027-3038.
67. Pratt ZL, Kuzembayeva M, Sengupta S, Sugden B. 2009. The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines. Virology 386:387-397.
68. Tempia-Caliera AA, Horvath LZ, Zimmermann A, Tihanyi TT, Korc M, Friess H, Buchler MW. 2002. Adhesion molecules in human pancreatic cancer. J. Surg. Oncol. 79:93-100.
69. Rosette C, Roth RB, Oeth P, Braun A, Kammerer S, Ekblom J, Denissenko MF. 2005. Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis 26:943-950.
70. Roland CL, Harken AH, Sarr MG, Barnett CC, Jr. 2007. ICAM-1 expression determines malignant potential of cancer. Surgery 141:705-707.
71. Johnson JP, Stade BG, Holzmann B, Schwable W, Riethmuller G. 1989. De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc. Natl. Acad. Sci. U. S. A. 86:641-644.
72. Busson P, Zhang Q, Guillon JM, Gregory CD, Young LS, Clausse B, Lipinski M, Rickinson AB, Tursz T. 1992. Elevated expression of ICAM1 (CD54) and minimal expression of LFA3 (CD58) in Epstein-Barr-viruspositive nasopharyngeal carcinoma cells. Int. J. Cancer 50:863-867.
73. Tao Q, Srivastava G, Chan AC, Ho FC. 1995. Epstein-Barr-virusinfected nasopharyngeal intraepithelial lymphocytes. Lancet 345:1309-1310.
74. Speck P, Longnecker R. 2000. Infection of breast epithelial cells with Epstein-Barr virus via cell-to-cell contact. J. Natl. Cancer Inst. 92:1849-1851.
75. Shannon-Lowe CD, Neuhierl B, Baldwin G, Rickinson AB, Delecluse HJ. 2006. Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 103:7065-7070.
76. Shannon-Lowe C, Rowe M. 2011. Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cell-mediated transfer infection. PLoS Pathog. 7:e1001338. doi:10.1371/journal.ppat .1001338.
77. Nanbo A, Terada H, Kachi K, Takada K, Matsuda T. 2012. Roles of cell signaling pathways in cell-to-cell contact-mediated Epstein-Barr virus transmission. J. Virol. 86:9285-9296.
78. Chang Y, Tung CH, Huang YT, Lu J, Chen JY, Tsai CH. 1999. Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes. J. Virol. 73:8857-8866.
79. Viaud S, Thery C, Ploix S, Tursz T, Lapierre V, Lantz O, Zitvogel L, Chaput N. 2010. Dendritic cell-derived exosomes for cancer immunotherapy: what's next? Cancer Res. 70:1281-1285.